ULK1 and in situ carcinoma: A significant increase in Ulk-1 concentrations was noted in the kidneys of the CIS-treated Gal-3 wild-type mice compared to Gal-3 wild-type sham control mice, demonstrating statistical significance (p < 0.01) (Figure 10B).